Skip to main content
Equibles

BARCLAYS PLC

Position in CLLS — Cellectis S.A.

CIK 312069 LONDON, X0
Back to CLLS Full portfolio

Position in CLLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$710
+$666 QoQ
Shares Held
224
+700.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in CLLS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $710 224
2023-09-30 $44 28
2023-06-30 $55 28
2023-03-31 $54 28
2022-12-31 $58 28
2022-09-30 $1,488 650
2021-12-31 $18,870 2,324
2021-09-30 $549,644 43,588
2021-06-30 $980,627 63,389
2021-03-31 $469,195 23,216
2020-12-31 $122,527 4,528
2020-09-30 $8,972 485